Goodwin Procter has hired Bosco Yiu as a private equity partner in Hong Kong from Cleary Gottlieb Steen & Hamilton, where he was an associate.

Yiu is experienced in representing private equity firms, investment banks and public and private companies in connection with M&A, joint ventures, IPOs on the Hong Kong Stock Exchange and general Hong Kong corporate regulatory and compliance advice. He has particular expertise with Hong Kong takeovers, privatisation, private and public M&A, reorganisations and equity capital markets transactions.

Goodwin has been slowly rebuilding its Hong Kong office since several lawyers departed in 2016. That year, corporate partners Christopher Yu and Andrew Yang headed to local firm Howse Williams Bowers and Addleshaw Goddard, respectively, and disputes specialist Jay Chiu left for K&L Gates, where he was made a partner. Corporate partner Nian Qing also left that year.

Since then, Goodwin has recruited private equity partners Douglas Freeman and Victor Chen from Paul Hastings last year and relocated private investment funds partner Greg Barclay from its London office.

With the new additions, Goodwin now has 17 lawyers in Hong Kong, including six partners.

Related Articles

CC, Slaughters advise as HK-listed SciClone goes private for $1.13 bln

Clifford Chance has advised the Hong Kong-listed SciClone Pharmaceuticals on an offer to take it private by healthcare-focused private equity firm GL Capital, with Slaughter and May acting for the buyer’s financial adviser, Capital Corporation Hong Kong Securities (CICC).

Latham taps rival MoFo for M&A partner in Tokyo

by Nimitt Dixit |

Global law firm Latham & Watkins has turned to U.S. rival Morrison & Foerster to bolster its M&A capabilities in Japan with the hire of deals and private equity partner Yohei Nakagawa in Tokyo.

Clifford Chance, Nishimura, MHM lead on CVC’s $1.2 bln acquisition of Sogo Medical Group

by Mari Iwata |

Clifford Chance and Nishimura & Asahi have acted for private equity firm CVC Capital Partners on its 17-billion-yen ($1.2 billion) acquisition of Sogo Medical Group, Japan’s fifth-biggest pharmacy by store numbers. Sogo was represented by Mori Hamada & Matsumoto.